CLCharles T. Lutz

Charles T. Lutz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Charles T. Lutz has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Steven R. Presnell

    Department of Pathology and Laboratory Medicine, College of Medicine, University of Kentucky, Lexington, KY, USA

    5 shared publications
  • Ahmad Al-Attar

    Department of Pathology and Laboratory Medicine, College of Medicine, University of Kentucky, Lexington, KY, USA

    3 shared publications
  • Brent J. Shelton

    Department of Internal Medicine, University of Kentucky , Lexington, KY 40536

    2 shared publications
  • Charlotte A. Peterson

    Department of Rehabilitation Sciences, College of Health Sciences, University of Kentucky, Lexington, KY, USA

    2 shared publications
  • Huei-Wei Chan

    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY 40536

    2 shared publications
  • Mikel B. Moore

    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY 40536

    2 shared publications

Latest Publications

  • Open Access

    Data correlations between gender, cytomegalovirus infection and T cells, NK cells, and soluble immune mediators in elderly humans

    by Ahmad Al-Attar, Steven R. Presnell, Charlotte A. Peterson, D. Travis Thomas, Charles T. Lutz


  • Falsely Incompatible B-cell Flow Cytometry Crossmatch After Pronase Treatment: A Case Report

    by J.D. Hart, C.T. Lutz, C.D. Jennings, J.R. May, K. Nelson, S. Jacobs, C.W. Hoopes


  • Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells

    by Charles T. Lutz

    Purpose of review To describe the structural basis of human leukocyte antigen (HLA) Bw4 and Bw6 epitopes that are recognized by antibodies and the KIR3DL1 natural killer cell receptor. Recent findings Molecular modeling and X-ray crystallography have refined our understanding of Bw4 and Bw6. These epitopes had been defined by comparison of HLA allele sequences and by site-directed mutagenesis. Anti-Bw4 and anti-Bw6 antibodies and KIR3DL1 receptors recognize HLA α-1 α-helix residues 77–83 in combination with other HLA regions. The variability of HLA sequences within the 77–83 region and at other sites indicates that the Bw4 epitope is complex. Adding complexity, HLA-bound peptides influence Bw4 and Bw6 epitopes. These structures are recognized by diverse antibodies and KIR3DL1 allotypes. This diversity allowed a Bw4+ patient to produce anti-Bw4 antibody without breaking self-tolerance. Summary Bw4 and Bw6 epitopes are best regarded as families of related structures that are recognized by a diverse array of antibodies and KIR3DL1 allotypes.


  • Open Access

    Human NK Cells Proliferate and Die In Vivo More Rapidly than T Cells in Healthy Young and Elderly Adults

    by Charles T. Lutz, Anush Karapetyan, Ahmad Al-Attar, Brent J. Shelton, Kimberly J. Holt, Jason H. Tucker, Steven R. Presnell

    NK cells are essential for health, yet little is known about human NK turnover in vivo. In both young and elderly women, all NK subsets proliferated and died more rapidly than T cells. CD56bright NK cells proliferated rapidly but died relatively slowly, suggesting that proliferating CD56bright cells differentiate into CD56dim NK cells in vivo. The relationship between CD56dim and CD56bright proliferating cells indicates that proliferating CD56dim cells both self-renew and are derived from proliferating CD56bright NK cells. Our data suggest that some dying CD56dim cells become CD16+CD56− NK cells and that CD16−CD56low NK cells respond rapidly to cellular and cytokine stimulation. We propose a model in which all NK cell subsets are in dynamic flux. About half of CD56dim NK cells expressed CD57, which was weakly associated with low proliferation. Surprisingly, CD57 expression was associated with higher proliferation rates in both CD8+ and CD8− T cells. Therefore, CD57 is not a reliable marker of senescent, nonproliferative T cells in vivo. NKG2A expression declined with age on both NK cells and T cells. Killer cell Ig-like receptor expression increased with age on T cells but not on NK cells. Although the percentage of CD56bright NK cells declined with age and the percentage of CD56dim NK cells increased with age, there were no significant age-related proliferation or apoptosis differences for these two populations or for total NK cells. In vivo human NK cell turnover is rapid in both young and elderly adults.


  • Proteasome Regulation of ULBP1 Transcription

    by James E Butler, Mikel B. Moore, Steven R. Presnell, Huei-Wei Chan, N. Jan Chalupny, Charles T. Lutz

    Killer lymphocytes recognize stress-activated NKG2D ligands on tumors. We examined NKG2D ligand expression in head and neck squamous cell carcinoma (HNSCC) cells and other cell lines. HNSCC cells typically expressed MHC class I chain-related gene A (MICA), MICB, UL16-binding protein (ULBP)2, and ULBP3, but they were uniformly negative for cell surface ULBP1 and ULBP4. We then studied how cancer treatments affected NKG2D ligand expression. NKG2D ligand expression was not changed by most cancer-relevant treatments. However, bortezomib and other proteasome inhibitor drugs with distinct mechanisms of action dramatically and specifically up-regulated HNSCC ULBP1 mRNA and cell surface protein. Proteasome inhibition also increased RNA for ULBP1 and other NKG2D ligands in nontransformed human keratinocytes. Proteasome inhibitor drugs increased ULBP1 transcription by acting at a site in the 522-bp ULBP1 promoter. Although the DNA damage response pathways mediated by ATM (ataxia-telangiectasia, mutated) and ATR (ATM and Rad3-related) signaling had been reported to up-regulate NKG2D ligand expression, we found that ULBP1 up-regulation was not inhibited by caffeine and wortmannin, inhibitors of ATM/ATR signaling. ULBP1 expression in HNSCC cells was not increased by several ATM/ATR activating treatments, including bleomycin, cisplatin, aphidicolin, and hydroxyurea. Ionizing radiation caused ATM activation in HNSCC cells, but high-level ULBP1 expression was not induced by gamma radiation or UV radiation. Thus, ATM/ATR signaling was neither necessary nor sufficient for high-level ULBP1 expression in human HNSCC cell lines and could not account for the proteasome effect. The selective induction of ULBP1 expression by proteasome inhibitor drugs, along with variable NKG2D ligand expression by human tumor cells, indicates that NKG2D ligand genes are independently regulated.


  • Open Access

    Functional redundancy of transcription factor-binding sites in the killer cell Ig-like receptor (KIR) gene promoter

    by Steven R. Presnell, Lei Zhang, Cecilia A. Ramilo, Huei-Wei Chan, Charles T. Lutz

    Variegated expression of inhibitory killer cell Ig-like receptors (KIRs) for MHC class I molecules helps NK cells distinguish normal from aberrant self and avoid autoreactivity. Prior studies of KIR promoters have produced conflicting results and no cis-acting sites have been independently confirmed. We took a comprehensive linker-scanning mutagenesis approach and substituted 24 consecutive 10-bp segments in the human KIR3DL1 promoter. Our analysis revealed eight segments that activated and three segments that repressed KIR transcription. Site-directed mutagenesis and electrophoretic mobility shift assays indicated that optimal KIR transcription requires a proximal Ets site that binds several Ets family members, a cAMP response element (CRE), a Runx site and a site that mediates complex interactions between Ets family members, signal transducer and activator of transcription 5 (STAT5) and YY1; Sp1 also contributes to KIR transcription. KIR transcription was greatly reduced by several compound mutations and was abrogated by a combination of mutations that affected the proximal Ets site, and the CRE, Runx, Sp1 and Ets/STAT sites. The many transcription factors that contribute to KIR transcription are partially redundant in the setting of transient transfection assays, helping to explain why only 0–2 activating sites had been reported in each of three prior studies. We propose that the multiplicity of transcription factors enables NK cells to sustain continuous KIR expression in diverse cellular and cytokine milieus, thus preventing NK autoreactivity.


  • Reciprocal age related change in natural killer cell receptors for MHC class I

    by Charles T. Lutz, Mikel B. Moore, Sarah Bradley, Brent J. Shelton, Susan K. Lutgendorf